Scribe Therapeutics Inc. (SCTX) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Scribe Therapeutics Inc. (SCTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $513.0M, listed on NASDAQ, employing roughly 89 people, carrying a beta of 0.00 to the broader market. Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. Led by Benjamin L. Oakes, public since 2026-07-24.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for SCTX as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →